The effects of iMPZ beta-tubulin inhibitors on proliferation in MDA-MB-231, SH-SY5Y,and DLD-1 cancer cells, as well as their influence on beta-tubulininhibition, colonization, cell migration, cell cycle progression,and apoptosis in MDA-MB-231 cells, were investigated. Here, TUBB is linked to cancer.